Dry Eye Disease Market, By Disease Type (Aqueous Deficient Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By Product (Topical Corticosteroids, Cyclosporine, Oral Omega Supplements, Punctual Plugs, and Artificial Tears), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Dry Eye Disease Market was valued at US$ 7 Billion in 2024 and is projected to grow at a CAGR of 7.20% to reach US$ 14.1 Billion by 2034.

[PDF] Dry Eye Disease has become a common condition which occurs when eye tears aren’t able to provide an adequate lubrication for eyes and occurs if an eye do not produce enough tears. Hormonal changes and older age are the common reasons of dry eye disease.

Dry Eye Disease Market Drivers and Restrains:

Growing geriatric population and prevalence of dry eye disease to fuel market growth

Growing geriatric population across globe has become major contribution in market growth. Advancement in medical technologies has increased lifespan of humans in last decade. Rising ageing population coupled with growing eye-related disorders has boost the demand for market growth. Further, rising adoption of unhealthy lifestyle and prolonged use of laptops, mobiles, and reduction in blinking rate of an individual across globe has contributed in Dry Eye Disease market growth.

According to American Academy of Ophthalmology, (2015) the dry eye syndrome increases with age and nearly 1.68 million of men with age 50 & over and 3.2 million women with age 50 & over are affected by dry eye disease where, millions of people are effected with eye infections each year in United States.

For instance, in 2017 (PubMed Central), according to United Nations, the geriatric population aged 60 years or above across globe will triple by 2050, and rapidly growing geriatric population has increased likelihood of chronic and eye-related diseases.

Restrains:

However, high cost of treatment and drugs has hampered the demand for Dry Eye Disease Market growth.

Dry Eye Disease Market Segmentation:

Dry Eye Disease Market is segmented based on Disease Type, Product, Distribution Channel, and Region.

Disease Type Insight

On the basis of Disease Type, Dry Eye Disease Market is segmented into Aqueous Deficient Dry Eye Syndrome, Evaporative Dry Eye Syndrome.

Product Insights

On the basis of Product, Dry Eye Disease Market is segmented into Topical Corticosteroids, Cyclosporine, Oral Omega Supplements, Punctual Plugs, and Artificial Tears.

Distribution Channel Insights

On the basis of Distribution Channel, Dry Eye Disease Market is segmented into Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.

Dry Eye Disease Market Regional Insights:

On region the Dry Eye Disease Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period due to rising prevalence of dry eyes disorder, growing geriatric population, continuous technological development, and increased demand for anti-inflammatory drugs.

Asia Pacific market is estimated to witness a fastest revenue share over the forecast period due to growing population, increased prevalence of dry eye disease, improved healthcare infrastructure and presence of major players such as Santen Pharmaceuticals and Otsuka Pharmaceuticals Co. Ltd., expected to drive market.

Report Scope:

Attribute	Details
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Disease Type - Aqueous Deficient Dry Eye Syndrome, Evaporative Dry Eye Syndrome By Product - Topical Corticosteroids, Cyclosporine, Oral Omega Supplements, Punctual Plugs, and Artificial Tears By Distribution Channel- Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034

Dry Eye Disease Market Key Players:

The key players operating the Dry Eye Disease Market includes, AbbVie Inc., Johnson & Johnson Services Inc., Otsuka Pharmaceuticals Co. Ltd., Novartis AG, AFT Pharmaceuticals, OASIS Medical, Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Ltd., Bausch & Lomb, and Others.

Recent Development:

  The New Launched Product News,

·In April 2023, Sun Pharmaceutical Industries Ltd., (India) launched new medication for treating dry eye disease. The new launched ‘Cequa’ has become the first dry eye treatment available in India which is delivered with latest nanomicellar technology.

·In June 2023, the U.S. FDA (Food and Drug Administration) has approved two novel therapies for patients with dry eye disorder. The new approved therapies are ‘Miebo’, that address the excessive tear evaporation in dry eye and ‘Veyve’ a preservative-free and water-free solution based on EyeSol technology.

Key Issues Addressed

1. Company Profiles

• AbbVie Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Johnson & Johnson Services Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Otsuka Pharmaceuticals Co. Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Novartis AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• AFT Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• OASIS Medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Santen Pharmaceutical Co. Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Takeda Pharmaceutical Company Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Bausch & Lomb
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

1. The Last Word
   • Future Impact
   • About Us
   • Contact

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for medical carts Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Disease Type
     • Market Snippet, By Product
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restrains
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Dry Eye Disease Market, By Disease Type, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Aqueous Deficient Dry Eye Syndrome
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Evaporative Dry Eye Syndrome
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

1. Dry Eye Disease Market, By Product, Forecast Period up to 10 Years, (US$ Bn)
   • Overview                                      
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
     • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
     • Segment Trends
   • Topical Corticosteroids
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
   • Cyclosporine
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
   • Oral Omega Supplements
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
   • Punctual Plugs
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
   • Artificial Tears
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
2. Dry Eye Disease Market, By Distribution Channel, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospital Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Online Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Retail Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

1. Dry Eye Disease Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
     • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
       • UK
       • France
       • Germany
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
       • India
       • Japan
       • South Korea
       • China
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
     • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years

• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Disease Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Distribution Channel, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis